Tamryn Anderson
Psychiatric/Mental Health · Breckenridge, TXNPI 1457981458
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $13,042 with a category attached, or 76.7%. AbbVie accounts for 87.4% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $11,264, more than ten times the $297 reported in 2021. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $108.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Neurocrine Biosciences, Inc.$575
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$218
- Otsuka America Pharmaceutical, Inc.$145
- Alkermes, Inc.$142
- Teva Pharmaceuticals USA, Inc.$98
- plus $466 from 11 others
What the payments were for
- Speaking & faculty fees$10,00077%
- Travel & lodging$9687%
- Food & beverage$2,07116%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $11,399 |
| Neurocrine Biosciences, Inc. | 26 | $575 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $218 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Alkermes, Inc. | 7 | $142 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Avanir Pharmaceuticals, Inc. | 4 | $68 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Indivior Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $59 |
| AstraZeneca | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Boehringer Ingelheim | 2 | $41 |
| Lundbeck LLC | 1 | $29 |
| Johnson & Johnson | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$10,884
How this compares
$13,042 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 20 | $58,643 |
| RexultiBrexpiprazole | 19 | $30,546 |
| VraylarCariprazine Hcl | 20 | $24,764 |
| TrintellixVortioxetine Hydrobromide | 13 | $7,285 |
| Aripiprazole | 17 | $6,493 |
| BelsomraSuvorexant | 12 | $5,493 |
| Atomoxetine Hcl | 23 | $1,116 |
| Duloxetine Hcl | 87 | $1,021 |
| Lamotrigine | 127 | $914 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $501 |
| Mirtazapine | 21 | $487 |
| Trazodone Hcl | 62 | $400 |
| Sertraline Hcl | 54 | $387 |
| Olanzapine | 33 | $333 |
| Gabapentin | 22 | $319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $145 | $89,18939 claims |
| AbbVieVraylar | $11,399 | $24,76420 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $59 | $7,28513 claims |
| MerckBelsomra | $13 | $5,49312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Breckenridge
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.